Health authorities have expanded access to oral antiviral treatments for Covid-19 to millions of Australians.
As of Monday, all Australians over 70 with Covid are eligible for two antivirals – Lagevrio and Paxlovid – on the Pharmaceutical Benefits Scheme, as are a greater number of people at risk of severe disease.
